Company Description
Previously raised $3.6M from a single private investment fund in Florida. "We bring healthcare universe to your fingertips, to support your uninterrupted journey for better care, empowering you to master your own health.We help payers, providers and retailers improve their service quality, surge patient satisfaction, automate B2B processes, increase efficiency and throughput, slash overhead costs, expand markets, grow revenues and margins, altogether."David VakhtangishviliCEO @ Andromeda HealthHarvard Business School Alumni
Management Team / Advisory Board Bios
David Vakhtangishvili
CEO
Harvard Business School alumni with +25 years of senior executive experience: 10 years in Andersen and EY (head of audit & advisory practice), 9 years in Banking (CFO of a large, FTSE 250 public bank), 8 years in healthcare (CFO, CIO and CRO of a large public healthcare group). Track records: 3 IPOs and 4 Eurobonds on LSE, +50 M&As, raised over $2.8 billion capital in total, lead a 10-year, consecutive unbreakable record of a Triple Double growth (+20% in Revenue, +20% in Profits, +20% in Capital), +80 ERP implementations, EBRD Global Gold Medal winner for the best social innovation in healthcare. Studied AI at MIT.
George Vakhtangishvili
COO
Free University alumni with +15 years of senior executive experience: 3 years in EY (Senior Manager), 4 years in Banking (CFO and CRO of a large bank in Ukraine), 5 years in real estate development (CEO of "m2"), 7 years in Private Equity (partner in a public PE firm and an operating CEO of its investment in a large utility group operating in water supply and renewable energy). Track records: 1 IPO and 2 Eurobonds on LSE, +40 M&As and direct funding projects, raised over $1.5 billion capital in total, +10 ERP implementations.
Peter Brean
President of CHAT*
The University of Chicago Booth and University of Notre Dame alumni, a serial healthcare entrepreneur with +30 years of senior executive experience, owning and managing: a) a revenue cycle company; b) physician practice management company focused on neurology and neurosurgery; c) stereotactic radiosurgery centers (acquired first Gamma Knife in the US); and d) large acute-care hospital specializing in brain, spine and joint surgeries (in Top 5% of HealthGrades rating), successfully exited at +$100 million valuation.
*Comprehensive Healthcare Andromeda Technology LLC (“CHAT”), a subsidiary of Andromeda Health.